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ABSTRACT
Introduction: Osteoporosis is a skeletal system disease characterized by decline of bone mass and deterio-
ration of bone microarchitecture, which leads to increased bone fragility and, consequently, a greater risk of 
fractures. Postmenopausal osteoporosis generally occurs between 51 and 75 years of age following ovarian 
failure. Our aim was to investigate if specific lifestyle habits, i.e., smoking cigarettes and physical activity, as 
well as the intake of dietary supplements, affect bone mineral density (BMD) in postmenopausal women.
Methods: Ultrasound (US) and dual energy X-ray absorptiometry (DEXA) data, obtained between 2008 
and 2009 year, were retrospectively reviewed for 150 women in postmenopause, 50-65 years old, who 
live in Sarajevo Canton. The women were classified into two groups: Group A (75 postmenopausal women 
who underwent US of the left heel bone); control group B (75 postmenopausal women who underwent 
US of the left heel bone and had a DEXA scan of the lumbar spine and left hip).
Results: The study included 150 women with the average age of 55.39 years. In the total sample, 24.7% 
of women took calcium and vitamin D supplements, and no statistically significant difference was observed 
between the groups. In the total sample, the prevalence of osteoporosis was significantly different between 
smokers and nonsmokers; i.e., osteoporosis was more frequent in women who smoked cigarettes. On aver-
age, women in both groups reported low physical activity; the difference was not statistically significant.
Conclusions: Menopause is a known risk for osteoporosis. Our results showed that the length of meno-
pause is closely associated with osteoporosis occurrence.
Keywords: Osteoporosis; lifestyle habits; menopause; menopause length; ultrasound; DEXA scan????????????????????????????????????????????????UNIVERSITY OF SARAJEVO FACULTY OF HEALTH STUDIES © 2017 Amila Jaganjac, et al; licensee University of Sarajevo - Faculty of Health Studies. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distri-
bution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Osteoporosis is a condition characterized by a 
decrease in the density of bone and changes in tra-
becular bone microarchitecture, and it results in 
bone fragility as well as an increased risk of bone 
fractures (1,2). It is a very common disease affecting 
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over 75 million people in Europe, Japan, and the 
United States [U.S.] (3). According to The Surgeon 
General’s Report on Bone Health and Osteoporosis 
from 2004, one in two Americans will have, or be 
at high risk of developing osteoporosis of the hip or 
other bones, in 2020 year (4). In 2003, 7.8 million 
of Germans (6.5 million of women) suffered osteo-
porosis (5).
Although there are no symptoms at the early stages, 
bone microfracture and skeletal deformities in oste-
oporosis may cause chronic pain and disability at 
later stages. This condition is associated with differ-
ent clinical characteristics, but it is mostly related 
to aging and menopause. The prevalence of post-
menopausal osteoporosis accounts for the overall 
female-male ratio of 2:1 to 3:1. Approximately 25% 
of women experience bone fracture at the age of 
65 years, and around 50% at the age of 90  (2,6). 
Women have 30% lower bone mineral density 
(BMD) in their eighties compared to the measure-
ments in the third decade of life (7). Among the 
causes of osteoporosis are also some medications, 
including glucocorticoids, anticonvulsants, antiepi-
leptic drugs, inhibitors of proton pump, retinoids, 
and others (8). Also, during inflammation, activated 
T lymphocytes can contribute to increased bone 
resorption, by producing pro-inflammatory cyto-
kines that affect the biological activity of the bone 
cells (9). Osteoporosis-related fractures frequently 
occur in older women, and estrogen deficiency is 
associated with secondary osteoporosis. In addition, 
estrogen deficiency leads to increased production 
of pro-inflammatory cytokines by T lymphocytes, 
including TNF-α, IL-1, IL-6, IL-7, and IL-8 (9-11).
Long-term excessive alcohol consumption is a risk 
factor for decreased BMD, as well as low calcium 
and other nutrient intake, decreased body weight, 
cigarette smoking, and high caffeine intake (12). 
The biologically active form of vitamin D promotes 
calcium absorption in the small intestine and cal-
cium reabsorption in the kidneys (13). Vitamin D 
deficiency leads to decreased absorption of calcium 
and phosphorus which, in turn, increases the pro-
duction of parathyroid hormone (PTH); a condi-
tion known as secondary hyperparathyroidism. Due 
to PTH overproduction, and in order to maintain 
constant level of calcium in the blood, calcium is 
removed from the bones into the blood. In addition, 
renal excretion of phosphorus is increased. The direct 
consequence of these processes is decreased bone 
mineralization (low BMD) and the development 
of osteopenia or osteoporosis (14). In their review, 
del Ghianda et al. (15) discussed the relationship 
between menopause and thyroid function and the 
combined effect on the reduction of BMD (15).
A considerable amount of financial resources is 
appropriated for the treatment of osteoporosis and 
osteoporotic fractures. In Germany, the treatment of 
hip fractures only, imposes an annual economic bur-
den of €3 billion; in the United Kingdom (U.K.) this 
figure is estimated at £1.7 billion, which severely bur-
dens the healthcare systems in these countries (4,16). 
According to a study from 2010, 3.5 million of osteo-
porosis-related fractures were registered in European 
Union (EU) countries [17.7% of hip fractures and 
14.8% of spine fractures] (17). In the U.S., the prev-
alence of osteoporosis-related fractures is estimated 
at 1.5 million annually (18).
Osteoporosis can be classified as primary or second-
ary osteoporosis. Primary or involutional osteopo-
rosis is the more common form and the etiology is 
unknown. There are two types of primary osteopo-
rosis, type 1 and type 2. Type 1 osteoporosis occurs 
frequently in postmenopausal women (known also 
as postmenopausal osteoporosis). Type  2 or senile 
osteoporosis is prevalent in the elderly (19). Type 3 
or secondary osteoporosis occurs in both sexes 
at any age and is associated with different causes, 
including endocrine disease and genetic abnormal-
ities (1,20,21). Finally, idiopathic osteoporosis can 
affect juveniles, premenopausal women, and mid-
dle-aged men.
Postmenopausal osteoporosis occurs in women 15 
to 20  years of menopause. Fractures are evident 
in trabecular bone, usually in the distal forearm 
and vertebrae. These women also have estrogen 
deficiency (22) which increases bone remodeling 
and thus affects the balance between bone forma-
tion and bone resorption, i.e.  bone resorption is 
increased (23,24). After menopause, urinary excre-
tion of calcium is elevated and the inhibition of 
bone resorption associated with PTH release is low-
ered, which leads to increased loss of BMD (2,25). 
In addition, a study showed differences in the prev-
alence of osteoporosis and risk of fractures between 
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different racial groups and inside every group (26). 
Furthermore, considerable variation in the inci-
dence of fractures between several countries indi-
cates the importance of environmental factors in 
osteoporosis-related conditions (2).
The aim of this study was to investigate if specific 
lifestyle habits, i.e., smoking cigarettes and physical 
activity, as well as the intake of dietary supplements, 
affect BMD in postmenopausal women, aged 
between 50 and 65 years, and who live in Sarajevo 
Canton. We also assessed the difference in the effect 
of these factors on BMD between the postmeno-
pausal women with normal menstrual history and 
those with estrogen deficiency.
METHODS
Study groups
A total of 150 women in postmenopause, 
50-65 years old, who live in Sarajevo Canton were 
included in the study. The women were classified 
into two groups:
1. Group  A (75 postmenopausal women, aged 
between 50 and 65 years, who underwent ultra-
sound [US] of the left heel [calcaneus] bone).
2. Control group B (75 postmenopausal women, 
aged between 50 and 65 years, who underwent 
ultrasound [US] of the left heel [calcaneus] 
bone and had a dual energy X-ray absorpti-
ometry [DEXA] scan of the lumbar spine and 
left hip).
US examination and DEXA scan
The US data of the left heel bone obtained at the 
health practitioner’s office “AD” and DEXA scans 
of the lumbar spine (L1-L4) and left hip carried out 
at the Clinic for Radiology of University Clinical 
Center Sarajevo, between 2008 and 2009 year, were 
retrospectively reviewed for 150 postmenopausal 
women.
The DEXA scans were performed on a Hologic 
QDR-4000 (S/N 55680) scanner (General Electric, 
Milwaukee, USA). The results are reported as 
T scores which represent the number of units (stan-
dard deviations) that the bone density of a patient 
is above or below the average result (i.e.  ,what is 
normally expected in a healthy young person of the 
same sex).
Questionnaire
The questionnaire on clinical data of the partici-
pants included the following information:
•	 General	information	(name	and	surname,	sex,	




•	 Dietary	 supplement	 intake	 (calcium	and	vita-
min D3 supplements);
•	 Medical	 records	 of	 diseases	 that	 cause	
osteoporosis;
•	 Medical	 records	 of	 medications	 that	 cause	
osteoporosis.
Statistical analysis
Based on the questionnaire, we analyzed the differ-
ences in daily calcium intake through supplements, 
cigarette consumption and physical activity between 
Group  A and B (control) in relation to the men-
strual history of women (i.e. normal or with estro-
gen deficiency).
The results were grouped according to defined 
parameters and presented using descriptive and 
inferential statistics. Two major groups were 
defined: Case and control group; then, both groups 
were further classified according to different param-
eters. Descriptive statistics included: The number 
of cases, percentage, average value, standard devia-
tion (SD), and standard error of the mean (SEM), 
while inferential statistics comprised of the results of 
hypothesis testing, degree of freedom, and statistical 
significance. For non-parametric data (frequencies) 
differences between groups were tested by Chi-
square test and for parametric data Student’s t-test 
was used. The relationship between variables was 
assessed by correlation analysis.
RESULTS
A total of 150 women between 50 and 60  years 
old (average age 55.39  years) participated in this 
study. A  statistically significant difference in the 
average age was observed between Group A and B 
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[Student’s t test(143) = -3.843; p < 0.0001 (Table 1)]; 
furthermore, additional medical examinations were 
more frequently carried out in older women. The 
women from group  B also had statistically longer 
average length of menopause compared to Group A 
(t = -2.983; p = 0.003; Table 2).
On average, women in both groups reported low 
physical activity; the difference was not statistically 
significant (X2 = 0.048; p ≥ 0.05; Table  3). The 
following results also showed no significant differ-
ence between Group A and B: Number of smokers 
(X2 = 2.218; p > 0.05; Table 4); Ca and vitamin D 
supplementation (X2 = 2.296; p > 0.05; Table 5); in 
the total sample, 24.7% of women took calcium and 
vitamin D supplements; therapy for other chronic 
diseases (X2(3) = 2.883; p > 0.05; Table 6); in the total 
sample, most women (86.7%) did not receive addi-
tional therapy; and the number and type of fractures 
(X2(7) = 7.927; p > 0.05; Table 7).
There was no significant difference in the average 
weight, height, and body mass index (BMI) between 
Group A and B (weight t = 1.353, p > 0.05; height 
t = 0.999, p > 0.05; and BMI t = 1.020, p > 0.05; 
Table 8).
A significantly negative correlation was observed 
between the length of menopause and BMD deter-
mined by the US of heel bone (Pearson correlation 
coefficient was -0.246; p = 0.002); longer duration 
of menopause resulted in decreased BMD. The cor-
relation between BMD determined by DEXA of the 
hip and spine and the length of menopause was not 
significant (Figure 1).
Although lower BMI was observed in osteo-
porotic women compared to those without 
osteoporosis, this result was not statistically signif-
icant (t = 1.732; p = 0.085; Table  9). According 
to the US results for heel bone, a significant dif-
ference was observed in BMD between smokers 
and nonsmokers (X2(2) = 6.941; p = 0.031), while 
significant differences were not observed for BMD 
determined by DEXA scans of hip and spine (for 
hip X2(2) = 2.327; p = 0.312, for spine X
2
(2) = 1.448; 
p = 0.485; Table 10).
In the total sample, the prevalence of osteoporosis 
was significantly different between smokers and 
nonsmokers (X2 = 3.946; p = 0.047; Table  11). 
According the US results for heel bone, a sig-
nificant difference in the rate of bone mass loss 
was observed between women who took calcium 
and vitamin D supplements and those who did 
not (X2(2) = 7.534; p = 0.023); similar results were 
obtained for BMD determined by DEXA scan 
of spine (X2(2) = 6.104; p = 0.046). On contrary, 
no significant difference was observed in BMD 
assessed by the DEXA scan of hip between women 
who took supplements and those who did not 
(X2(2) = 1.374; p = 0.503). In the total sample, 
this difference was also not significant (Table 12). 
All three diagnostic methods showed no sig-
nificant difference in BMD between women in 
TABLE 1. Average age of women in two groups (with and 
without DEXA scan performed)  
DEXA scan Mean age N Standard deviation
Yes 53.68 75 4.930
No 57.09 75 5.928
Total 55.39 150 5.697
TABLE 2. Average length of menopause in two groups of postmenopausal women (with and without DEXA scan performed)
Menopause length Groups N Mean±SD Standard error of the mean
Ultrasound 75 4.48±8.349 0.964
Ultrasound+DEXA scan 75 8.50±8.154 0.942
SD: Standard deviation
FIGURE 1. Correlation between menopause length and bone 
mineral density determined by ultrasound (US) and DEXA scans 
in postmenopausal women.
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relation to the physical activity (for the US of heel 
bone X2(2) = 3.077; p = 0.215; for the DEXA scan 
of hip X2(2) = 0.167; p = 0.920; for the DEXA scan 
of spine X2(2) = 4.203; p = 0.122; Table 13).
DISCUSSION
In the total sample, the average age was 55.39 years. 
In a study on 836 women, Hadžiavdić et al. (27) 
showed the average age of 52.6  years, which is in 
agreement with our results.
We showed that out of 150 women, 24.7% took 
calcium and vitamin D supplements and the 
difference in BMD was not significant between 
women who took the supplements and those 
who did not (X2 = 2.296; p > 0.05). In the study 
of Kapetanović et al. (28), among 60 women, 
56.66% did not take the recommended daily 
amount of calcium (28).
Lips et al. (29) investigated types of patients who 
may benefit from calcium and vitamin D supple-
mentation; the authors reported that in the case 
when patient compliance was moderate or less, 
the benefits of supplements were not visible, espe-
cially in terms of fracture prevention (29). Among 
TABLE 3. Physical activity in two groups of postmenopausal 
women (with and without DEXA scan performed)
Physical 
activity
Ultrasound (%) Ultrasound+DEXA 
scan (%)
Total (%)
No 63 (84.0) 62 (82.7) 125 (83.3)
Yes 12 (16.0) 13 (17.3) 25 (16.7)
Total 75 (100.0) 75 (100.0) 150 (100.0)
TABLE 4. Cigarette smoking in two groups of postmenopausal 
women (with and without DEXA scan performed)
Cigarette 
consumption
Ultrasound (%) Ultrasound+DEXA 
(%)
Total (%)
No 60 (80.0) 51 (68.0) 111 (74.0)
Yes 15 (20.0) 24 (32.0) 39 (26.0)
Total 75 (100.0) 75 (100.0) 150 (100.0)
TABLE 5. Calcium+Vitamin D3 supplement intake in two groups of postmenopausal women (with and without DEXA scan 
performed)
Calcium+Vitamin D3 supplementation Ultrasound (%) Ultrasound+DEXA scan (%) Total (%)
No 61 (81.3) 52 (69.3) 113 (75.3)
Yes 14 (18.7) 23 (30.7) 37 (24.7)
Total 75 (100.0) 75 (100.0) 150 (100.0)
TABLE 6. Intake of medication for other diseases among postmenopausal women in two groups
Medication use Ultrasound (%) Ultrasound+DEXA scan (%) Total (%)
No 68 (90.7) 62 (82.7) 130 (86.7)
Corticosteroids 1 (1.3) 2 (2.7) 3 (2.0)
Thyroid hormone replacement 3 (4.0) 3 (4.0) 6 (4.0)
Other 3 (4.0) 8 (10.7) 11 (7.3)
Total 75 (100.0) 75 (100.0) 150 (100.0)
TABLE 7. Type and prevalence of fractures among postmenopausal women in two groups
Bone fracture Ultrasound (%) Ultrasound+DEXA scan (%) Total (%)
None 62 (82.7) 55 (73.3) 117 (78.0)
Forearm 2 (2.7) 5 (6.7) 7 (4.7)
Spine 0 (0.0) 2 (2.7) 2 (1.3)
Hip 0 (0.0) 2 (2.7) 2 (1.3)
Other 10 (13.3) 8 (10.7) 18 (12.0)
Spine and forearm 1 (1.3) 1 (1.3) 2 (1.3)
Spine and other 0 (0.0) 1 (1.3) 1 (0.7)
Forearm and other 0 (0.0) 1 (1.3) 1 (0.7)
Total 75 (100.0) 75 (100.0) 150 (100.0)
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50 women with osteoporosis, Kern (30) reported 
that 56% of these patients daily consumed only 
half a liter of milk, despite being aware that milk 
is the best food source of calcium. Calcium sup-
plements occasionally took 38% of patients, 36% 
regularly, and 26% of patients did not take the sup-
plements (30).
Different studies showed that low BMI is a risk 
factor for low BMD (31). In our study, there was 
no significant difference in the average weight, 
height, and BMI between Group A and B (weight 
t = 1.353, p > 0.05; height t = 0.999, p > 0.05; and 
BMI t = 1.020, p > 0.05). Milenković et al. (23) 
showed that among 186  female participants, oste-
oporosis was more frequent in older women, with 
lower height and BMI, while Muftić (32) reported 
an average BMI of 21.13 among 100 female partic-
ipants, which is in the range of normal weight (32). 
In the study of Kern (30), 56% of women with oste-
oporosis were overweight (30).
In our study, lower BMI was observed in osteopo-
rotic women compared to those without osteopo-
rosis, but this result was not statistically significant 
(t = 1.732; p = 0.085). In the study of Kapetanović 
et al. (28), 6.66% of women out of 60 female par-
ticipants had lower BMI (28). In a study of 189 
pre- and post-menopausal Irish women, Cummins 
et al. (33) reported that 59% of women had low 
BMD. Age, family history, smoking cigarettes, met-
abolic and mechanical lifetime physical activity, and 
TABLE 8. Average values of body mass index (BMI), weight, and height among postmenopausal women in two groups
Parameter Diagnostic method N Mean±SD Standard error of the mean
BMI Ultrasound 75 26.272±3.8845 0.4485
DEXA scan+Ultrasound 75 25.647±3.6175 0.4177
Weight Ultrasound 75 71.80±10.418 1.203
DEXA scan+Ultrasound 75 69.41±11.170 1.290
Height Ultrasound 75 165.93±6.725 0.777
DEXA+Ultrasound 75 164.88±6.171 0.713
SD: Standard deviation
TABLE 9. Body mass index (BMI) in postmenopausal women in relation to bone mineral density (BMD) determined by 
ultrasound (US) and DEXA scans
Diagnostic method/Diagnosis US of heel bone DEXA scan of hip DEXA scan of spine
Average BMI Average BMI Average BMI
Normal finding 25.964 27.874 28.220
Osteopenia 26.149 25.505 25.758
Osteoporosis 25.427 25.157 25.353
Total average 25.959 25.647 25.647
TABLE 10. Bone mineral density in relation to smoking status in postmenopausal women
Diagnostic method Cigarette smoking Normal finding (%) Osteopenia (%) Osteoporosis (%) Total (%)
Ultrasound of heel bone Yes 10 (25.6) 17 (43.6) 12 (30.8) 39 (100)
No 42 (37.8) 55 (49.5) 14 (12.6) 111 (100)
DEXA scan of hip Yes 3 (12.5) 4 (16.7) 17 (70.8) 24 (100)
No 8 (15.7) 16 (31.4) 27 (52.9) 51 (100)
DEXA scan of spine Yes 2 (8.3) 4 (16.7) 18 (75.0) 24 (100)
No 3 (5.9) 15 (29.4) 33 (64.7) 51 (100)
TABLE 11. Prevalence of osteoporosis among women in 
relation to cigarette smoking
Diagnosis Cigarette consumption
No Yes Total
Normal finding 74 19 93
Osteoporosis 37 20 57
Total 111 39 150
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weight accounted for 39% of the variance in lumbar 
BMD in these women (33).
Our results showed no significant difference 
in the number of smokers between the women 
with osteoporosis and those without osteoporo-
sis (X2 = 2.218; p > 0.05), and this result is not 
in correlation with other studies. For example, 
Kapetanović et al. (28) showed 63.33% of smokers 
in a sample of 60 women, while 64% of women 
were smokers in the study of Kern (30). Kanis et 
al. (3) reported that smoking cigarettes was signifi-
cantly associated with higher risk of fractures [rel-
ative risk (RR) = 1.25; with 95% confidence inter-
val (CI) = 1.15-1.36)] (3). In a 5-year longitudinal 
study, Rudäng et al. (34) showed a negative effect of 
smoking on BMD (34).
According to Fini et al. (35), overweight and obe-
sity protect bone and reduce the risk of fracture and 
the development of osteoporosis in older adults. 
On contrary, extreme obesity (BMI >40 kilogram/
meter squared) appears be a risk factor for osteopo-
rosis. Similarly, moderate alcohol consumption may 
have a protective effect, but excessive alcohol con-
sumption leads to reduction in BMD. The authors 
also indicated smoking as risk factor for osteopo-
rosis, by interfering with estrogens, calcium and 
vitamin D (35).
Low physical activity is a risk factor for osteoporosis 
due to its effect on bone remodeling and resorp-
tion (36). It is also associated with a decrease in the 
mass of muscles, which leads to insecure walking 
and frequent falls. In our study, women in both 
groups reported, on average, low physical activity, 
with no statistical difference between the two groups 
(X2 = 0.048; p ≥ 0.05). In a sample of 350 female 
participants, Avdić and Kapetanović  (37) showed 
that 229 of women did not have any physical activ-
ity (37). Kapetanović et al. (28) reported 33.33% 
(total sample of 60) women with low physical activ-
ity (28).
In our study, all three diagnostic methods showed 
no significant difference in BMD between women 
in relation to the physical activity (for the US of 
heel bone X2(2) = 3.077; p = 0.215; for the DEXA 
scan of hip X2(2) = 0.167; p = 0.920; for the DEXA 
scan of spine X2(2) = 4.203; p = 0.122). Among 30 
postmenopausal women with osteoporosis, Aksentić 
et al. (24) reported 86% of those with inadequate 
physical activity (24).
Bidoli et al. (26) carried out a study on 1373 women 
in the North-East of Italy. They investigated physi-
cal activity for three specific periods of life in this 
population, and indicated that past and recent phys-
ical activity leads to increased BMD in middle-aged 
TABLE 12. Prevalence of osteoporosis among women in relation to calcium and vitamin D3 supplement intake
Diagnostic method Calcium+Vitamin D3 intake Normal finding (%) Osteopenia (%) Osteoporosis (%) Total (%)
Ultrasound of heel bone Yes 8 (21.6) 25 (67.6) 4 (10.8) 37 (100)
No 44 (38.9) 47 (41.6) 22 (19.5) 113 (100)
DEXA scan of hip Yes 5 (21.7) 6 (26.1) 12 (52.2) 23 (100)
No 6 (11.5) 14 (26.9) 32 (61.5) 52 (100)
DEXA scan of spine Yes 4 (17.4) 5 (21.7) 14 (60.9) 23 (100)
No 1 (1.9) 14 (26.9) 37 (71.2) 52 (100)
TABLE 13. The effect of physical activity on bone mineral density in postmenopausal women determined by ultrasound (US) 
or DEXA scans
Diagnostic method Physical activity Normal finding (%) Osteopenia (%) Osteoporosis (%) Total (%)
US of heel bone Yes 6 (24.0) 16 (64.0) 3 (12.0) 25 (100)
No 46 (36.8) 56 (44.8) 23 (18.4) 125 (100)
DEXA scan of hip Yes 2 (15.4) 4 (30.8) 7 (53.8) 13 (100)
No 9 (14.5) 16 (25.8) 37 (59.7) 62 (100)
DEXA scan of spine Yes 0 (0.0) 6 (46.2) 7 (53.8) 13 (100)
No 5 (8.1) 13 (21.0) 44 (71.0) 62 (100)
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women (26). In the study of Kern (30), 56% of 
women were not physically active and 44% of them 
reported occasional or recreational physical activ-
ity  (30). Other studies showed positive effects of 
physical activity on BMD (38,39).
In our study, no significant difference was observed 
in the number and type of fractures between women 
with and without osteoporosis (X2(7) = 7.927; 
p > 0.05).
CONCLUSION
The following are the highlights from our study: The 
average age of women in this study was 55.39 years. 
Irregular menstrual cycle was more common in 
women with osteoporosis. The length of meno-
pause was significantly associated with osteoporosis. 
Women with osteoporosis had more frequently low 
BMI (underweight). A significantly higher number 
of smokers was in the group of women with osteo-
porosis. Calcium and vitamin D supplement intake 
was not significantly associated with higher BMD 
in our sample. Both groups of women showed low 
physical activity.
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